<?xml version="1.0" encoding="UTF-8"?>
<p>Depressive symptoms were measured using the nine-item Patient Health Questionnaire-9 (PHQ-9) scale (Cronbach's alpha at baseline = 0.83) [
 <xref rid="pone.0240674.ref053" ref-type="bibr">53</xref>], a tool that has been validated in Vietnam [
 <xref rid="pone.0240674.ref054" ref-type="bibr">54</xref>]. A composite PHQ-9 score was calculated for each participant. Based on the standard scoring method used for the PHQ-9, those who scored zero to four were categorized as screening negative for depressive symptoms, and those who scored above four were categorized as screening positive for depressive symptoms [
 <xref rid="pone.0240674.ref055" ref-type="bibr">55</xref>]. A binary measure was also used as the distribution of PHQ-9 scores was highly skewed at baseline.
</p>
